Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
Go back to Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs| (NASDAQ: PGEN) | Delayed: 7.78 -0.09 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.87 | 52 Week High | $ | |||
| Open | $7.98 | 52 Week Low | $ | |||
| Day High | $8.04 | P/E | N/A | |||
| Day Low | $7.70 | EPS | $ | |||
| Volume | 9,578,103 | |||||

